Draft guidance consultation
You can now review and comment on this draft guideline.
The consultation closes on 2 February 2026 at 5pm.
How to comment
1. Register your organisation or comment as an individual
If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.
Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.
We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.
2. Read the consultation documents
Documents to comment on:
Evidence reviews:
- Evidence review A - Diagnostic age and CA125
- Evidence review B - Weight loss
- Evidence review C - Diagnostic endometrial HRT
Appendices:
- Appendices A - Age and CA125
- Appendices B - Weight loss
- Appendices C - Endometrial cancer HRT
Other information about the consultation:
- Committee membership list
- Committee Declarations of Interest register
- Developing NICE guidelines: how to get involved
- Final scope - for information
3. Add your comments
- You must use this form: Comments form
- You must declare any links with, or funding from, the tobacco industry
If you share similar views with another organisation, send a joint response.
Make sure you consider:
- The areas that will have the biggest impact on practice and be challenging to implement
- How to help users overcome challenges
- Developing NICE guidelines: how to get involved suggests some other areas to comment on.
4. Email the form to us
Email: SuspectedCancer@nice.org.uk
Deadline: 2 February 2026 at 5pm
This page was last updated: